Endocannabinoid system in psychotic and mood disorders, a review of human studies.
Endocannabinoid system in psychotic and mood disorders, a review of human studies.
复制标题
DOI:
10.1016/j.pnpbp.2020.110096
复制
发表时间:
2021-03-02
影响因子:
5.6
通讯作者:
Mizrahi R
中科院分区:
文献类型:
--
作者:
Garani R;Watts JJ;Mizrahi R
Despite widespread evidence of endocannabinoid system involvement in the pathophysiology of psychiatric disorders, our understanding remains rudimentary. Here we review studies of the endocannabinoid system in humans with psychotic and mood disorders. Postmortem, peripheral, cerebrospinal fluid and in vivo imaging studies provide evidence for the role of the endocannabinoid system in both psychotic and mood disorders. Psychotic disorders and major depressive disorder exhibit alterations of brain cannabinoid CB1 receptors and peripheral blood endocannabinoids. Further, these changes may be sensitive to treatment status, disease state, and symptom severity. Evidence from psychotic disorder extend to endocannabinoid metabolizing enzymes in the brain and periphery, whereas these lines of evidence remain poorly developed in mood disorders. A lack of studies examining this system in bipolar disorder represents a notable gap in the literature. Despite a growing body of productive work in this field of research, there is a clear need for investigation beyond the CB1 receptor in order to more fully elucidate the role of the endocannabinoid system in psychotic and mood disorders.
登录
查看更多内容
影响因子:
11.3
作者:
Chase, Kayla A.;Feiner, Benjamin;Sharma, Rajiv P.
通讯作者:
Sharma, Rajiv P.
影响因子:
4.7
作者:
Desfossés J;Stip E;Bentaleb LA;Lipp O;Chiasson JP;Furtos A;Venne K;Kouassi E;Potvin S
通讯作者:
Potvin S
影响因子:
5.7
作者:
Ceccarini, Jenny;De Hert, Marc;Van Laere, Koen
通讯作者:
Van Laere, Koen
影响因子:
7.6
作者:
Dalton, Victoria S.;Long, Leonora E.;Zavitsanou, Katerina
通讯作者:
Zavitsanou, Katerina
影响因子:
3.7
作者:
Hill, Matthew N.;Miller, Gregory E.;Carrier, Erica J.;Gorzalka, Boris B.;Hillard, Cecilia J.
通讯作者:
Hillard, Cecilia J.